Loading...
•
Jun 30, 2021
Progyny Q2 2021 Earnings Report
Progyny had a solid second quarter, with strong topline growth and ongoing margin expansion.
Key Takeaways
Progyny reported a record second-quarter revenue of $128.7 million, reflecting a 99% increase compared to the previous year. The company's net income was $18.7 million, or $0.19 per diluted share, a significant increase from the net loss of $1.1 million in the second quarter of 2020. The company had 182 clients as of June 30, 2021, as compared to 134 clients as of June 30, 2020.
Revenue was $128.7 million, a 99% increase as compared to the second quarter of 2020.
Fertility benefit services revenue was $92.3 million, a 99% increase from the second quarter of 2020.
Pharmacy benefit services revenue was $36.4 million, a 98% increase as compared to the second quarter of 2020.
Net income was $18.7 million, or $0.19 income per diluted share, compared to a net loss of $1.1 million in the second quarter of 2020.
Progyny
Progyny
Progyny Revenue by Segment
Revenue by Segment
Fertility Benefit Services Revenue
CapyFin.comPharmacy Benefit Services Revenue
CapyFin.com Forward Guidance
Progyny is providing financial guidance for the third quarter ending September 30, 2021, and the year ending December 31, 2021.
Revenue & Expenses
Visualization of income flow from segment revenue to net income